References
- Faber V, Dalgleish AG, Newell A, Malkowsky M. Inhibition of HIV replication in vitro by fusidic acid. Lancet 1987; 2: 827–828
- Maehlen T, Degré M. Fusidic acid inhibits HIV-infection in macrophage cultures. IV International Conference on AIDS, abstract 3067. 1988. Stockholm
- Richman DD, Mitasuya H, Broder S, Hostetler KY. Fusidic acid, HIV, and host cell toxicity. Lancet 1988; 1: 1051–1052
- Lloyd G, Atkinson T, Sutton PM. Effect of bile salt and of fusidic acid on HIV-1 infection of cultured cells. Lancet 1988; 1: 1418–1420
- Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987; 36: 15–155
- Youle MS, Hawkins DA, Lawrence AG, Tenant-Flowers M, Shanson DC, Gazzard BG. Clinical, immunological, and virological effects of sodium fusidate in patients with AIDS or AIDS-related complex (ARC): An open study. J AIDS 1989; 2: 59–62
- Kharazmi A, Nielsen H. Fusidic acid and human phagocyte function. J Antimicrob Chemother 1988; 22: 261–268
- Evans SW, Muir L, Newell A, Bountiff L, Dalgleish A. Sodium fusidate alters the half life of HIV p55 gag and binds a protein specific to infected cells. IV International Conference on AIDS, abstract 3527. 1988. Stockholm